In Vitro and In Vivo Activities of Sulfur-Containing Linear Bisphosphonates against Apicomplexan Parasites
Open Access
- 1 February 2017
- journal article
- research article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 61 (2)
Abstract
We tested a series of sulfur-containing linear bisphosphonates against Toxoplasma gondii , the etiologic agent of toxoplasmosis. The most potent compound (compound 22; 1-[( n -decylsulfonyl)ethyl]-1,1-bisphosphonic acid) is a sulfone-containing compound, which had a 50% effective concentration (EC 50 ) of 0.11 ± 0.02 μM against intracellular tachyzoites. The compound showed low toxicity when tested in tissue culture with a selectivity index of >2,000. Compound 22 also showed high activity in vivo in a toxoplasmosis mouse model. The compound inhibited the Toxoplasma farnesyl diphosphate synthase ( Tg FPPS), but the concentration needed to inhibit 50% of the enzymatic activity (IC 50 ) was higher than the concentration that inhibited 50% of growth. We tested compound 22 against two other apicomplexan parasites, Plasmodium falciparum (EC 50 of 0.6 ± 0.01 μM), the agent of malaria, and Cryptosporidium parvum (EC 50 of ∼65 μM), the agent of cryptosporidiosis. Our results suggest that compound 22 is an excellent novel compound that could lead to the development of potent agents against apicomplexan parasites.Keywords
Funding Information
- Consejo Nacional de Investigaciones Científicas y Técnicas (PIP 0797)
- HHS | National Institutes of Health (AI-102254)
- MINCyT | Agencia Nacional de Promoción Científica y Tecnológica (PICT 2012 0457)
This publication has 43 references indexed in Scilit:
- Toxoplasma gondii Relies on Both Host and Parasite Isoprenoids and Can Be Rendered Sensitive to AtorvastatinPLOS Pathogens, 2013
- Design, synthesis and biological evaluation of sulfur-containing 1,1-bisphosphonic acids as antiparasitic agentsEuropean Journal of Medicinal Chemistry, 2013
- New antibacterials for the treatment of toxoplasmosis; a patent reviewExpert Opinion on Therapeutic Patents, 2012
- Plasmodium falciparum heat shock protein 110 stabilizes the asparagine repeat-rich parasite proteome during malarial feversNature Communications, 2012
- Farnesyl pyrophosphate synthase modulators: a patent review (2006 – 2010)Expert Opinion on Therapeutic Patents, 2011
- Apicoplast isoprenoid precursor synthesis and the molecular basis of fosmidomycin resistance in Toxoplasma gondiiJournal of Experimental Medicine, 2011
- Molecular Characterization of a Novel Geranylgeranyl Pyrophosphate Synthase from Plasmodium ParasitesJournal of Biological Chemistry, 2011
- Lipophilic Bisphosphonates as Dual Farnesyl/Geranylgeranyl Diphosphate Synthase Inhibitors: An X-ray and NMR InvestigationJournal of the American Chemical Society, 2009
- Toxoplasma gondii Tic20 is essential for apicoplast protein importProceedings of the National Academy of Sciences, 2008
- Nitrogen-Containing Bisphosphonates as Carbocation Transition State Analogs for Isoprenoid BiosynthesisBiochemical and Biophysical Research Communications, 1999